Exact Mass: 514.26

Telmisartan

C33H30N4O2 (514.2369)

Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2805 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM.

Protoasukamycin

C31H34N2O5 (514.2468)

A polyketide that is (all-E)-7-(3-amino-4-hydroxyphenyl)hepta-2,4,6-trienoic acid in which the amino group has been acylated by an (all-E)-7-cyclohexylhepta-2,4,6-trienoyl group and in which the carboxy group has undergone formal condensation with the amino group of 2-amino-3-hydroxycyclopent-2-en-1-one to give the corresponding carboxamide. Protoasukamycin is an intermediate in the biosynthesis of asukamycin.

Lucidenic acid D2

C29H38O8 (514.2567)

Lucidenic acid D2 is found in mushrooms. Lucidenic acid D2 is a constituent of Ganoderma lucidum (reishi).

Glycinoeclepin C

C29H38O8 (514.2567)

Constituent of root of Phaseolus vulgaris (kidney bean). Glycinoeclepin C is found in pulses, yellow wax bean, and green bean. Glycinoeclepin C is found in pulses. Glycinoeclepin C is a constituent of root of Phaseolus vulgaris (kidney bean).

Cofaryloside

C26H42O10 (514.2778)

Cofaryloside is found in coffee and coffee products. Cofaryloside is a constituent of green coffee beans Constituent of green coffee beans. Cofaryloside is found in coffee and coffee products.

Capsianoside V

C26H42O10 (514.2778)

Constituent of fruits of Capsicum annuum variety grossum. Capsianoside V is found in many foods, some of which are orange bell pepper, italian sweet red pepper, red bell pepper, and fruits. Capsianoside V is found in fruits. Capsianoside V is a constituent of fruits of Capsicum annuum var. grossum

Cinncassiol D1 glucoside

C26H42O10 (514.2778)

Cinncassiol D1 glucoside is found in herbs and spices. Cinncassiol D1 glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon) Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol D1 glucoside is found in herbs and spices.

Cinncassiol D4 2-glucoside

C26H42O10 (514.2778)

Cinncassiol D4 2-glucoside is found in herbs and spices. Cinncassiol D4 2-glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon) Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol D4 2-glucoside is found in herbs and spices.

PA(2:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C25H39O9P (514.2332)

PA(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5-oxo-eicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C25H39O9P (514.2332)

PA(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 15-hydroxyleicosapentaenyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0)

C25H39O9P (514.2332)

PA(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0), in particular, consists of one chain of one 15-hydroxyleicosapentaenyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C25H39O9P (514.2332)

PA(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5-hydroxyleicosapentaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0)

C25H39O9P (514.2332)

PA(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0), in particular, consists of one chain of one 5-hydroxyleicosapentaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Roridine E

C29H38O8 (514.2567)

Albopilosin J

C26H42O10 (514.2778)

Tricalysioside J

C26H42O10 (514.2778)

9-Deacetyl-9-benzoyl-10-debenzoylbrevifoliol

C29H38O8 (514.2567)

Tricalysioside H

C26H42O10 (514.2778)

Cussovantoside B

C26H42O10 (514.2778)

Lucidenic acid D

C29H38O8 (514.2567)

Constituent of Ganoderma lucidum (reishi). Lucidenic acid D2 is found in mushrooms.

MCULE-4890335377

C26H42O10 (514.2778)

MCULE-9108329410

C28H38N2O7 (514.2679)

iso-Roridine E

C29H38O8 (514.2567)

CONFIDENCE isolated standard

roridin P

C29H38O8 (514.2567)

Dechloro-N-deepoxymaytansinol

C28H38N2O7 (514.2679)

propindilactone N

C29H38O8 (514.2567)

C29H38O8

C29H38O8 (514.2567)

Elaeodendroside D

C29H38O8 (514.2567)

Chaetoglobosin A

C32H38N2O4 (514.2831)

Elaeodendroside L

C29H38O8 (514.2567)

Pierisformoside B

C26H42O10 (514.2778)

novofumigatamide

C30H34N4O4 (514.258)

Nemorososide

C25H38O11 (514.2414)

2-O-Methylconfluentinsaeure|2-O-Methylconfluentsaeure

C29H38O8 (514.2567)

citreohybridone B|Citreohydridone B

C29H38O8 (514.2567)

4-butyl 1-(4-beta-D-glucopyranosyloxy-benzyl)ester (2R)-2-hydroxy-2-(2-methylpropyl)-butanedioic acid|armatuside|bletillin A

C25H38O11 (514.2414)

1alpha-methoxy-1,2-dihydrogedunin

C29H38O8 (514.2567)

15-isobutyrylhenrycinol A|henrycinol B

C31H34N2O5 (514.2468)

6R,7-dihydro-10-O-foliamenthoylaucubin

C25H38O11 (514.2414)

grayanoside B

C26H42O10 (514.2778)

isocitreohybridone B

C29H38O8 (514.2567)

2-Hydroxyfissinolide

C29H38O8 (514.2567)

SETOSUSIN

C29H38O8 (514.2567)

(5R,6R,7R)-5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyldibenzo[a,c][8]annulen-5-yl (2Z)-2-methylbut-2-enoate|kadsufolin A

C29H38O8 (514.2567)

7alpha,12alpha,14beta,15alpha-tetrahydroxyl-ent-kaur-16-ene-1-O-beta-D-glucopyranoside|glaucocalyxin G

C26H42O10 (514.2778)

3beta-ACETOXYDEOXYANGOLENSIC ACID, METHYL ESTER

C29H38O8 (514.2567)

anemarrhena B

C32H34O6 (514.2355)

methyl 3beta-acetoxy-l-oxomeliacate

C29H38O8 (514.2567)

rhodomicranol A

C29H38O8 (514.2567)

wittifuran N

C29H38O8 (514.2567)

Sativanine K|sativanine-K

C27H38N4O6 (514.2791)

ingenol 3-angelate 5,20-diacetate|ingenol-3-angelate-5,20-diacetate

C29H38O8 (514.2567)

pierisformoside H

C26H42O10 (514.2778)

Rhodomoside B

C26H42O10 (514.2778)

suavioside I

C26H42O10 (514.2778)

cinnacasside E

C25H38O11 (514.2414)

cytoglobosin D

C32H38N2O4 (514.2831)

A cytochalasan alkaloid found in Chaetomium globosum.

craiobioside B|craiobiotoxin VIII 3-O-beta-D-glucopyranoside

C26H42O10 (514.2778)

desacetylcinobufagin 3-succinate methyl ester

C29H38O8 (514.2567)

penochalasin G

C32H38N2O4 (514.2831)

10(20)-grayanotoxene-3beta,5beta,6beta,14beta,16alpha-pentol 3-O-beta-D-glucopyranoside|rhodomoside A

C26H42O10 (514.2778)

Elaphopilosin C

C29H38O8 (514.2567)

Pro Asn Ala Leu Ser

C22H38N6O8 (514.2751)

Asn Gly Pro Val Glu

C21H34N6O9 (514.2387)

LucidenicacidD

C29H38O8 (514.2567)

Lucidenic acid D2 is a triterpenoid. Lucidenic acid D is a natural product found in Ganoderma sinense and Ganoderma lucidum with data available.

Heterophdoid A

C26H42O10 (514.2778)

Telmisartan

C33H30N4O2 (514.2369)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2251 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 63 CONFIDENCE standard compound; INTERNAL_ID 8191 This spectrum was obtained at The Multidisciplinary Research Laboratory at Antenor Orrego Private University, Trujillo, La Libertad, Peru.The sample was obtained from a pharmacy.; The sample was dissolved in 1:1 acetonitrile:water and passed through a ACQUITY UPLC BEH C18 1.7um column at 0.6 mL/min in ramp of MPA: 0.1\\\% Formic Acid in water; MPB: 0.1\\\% Formic Acid in Acetonitrile; Contact us: http://www.upao.edu.pe/labinm/ Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM.

C28H38N2O7_Spiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalene]-7(3H)-acetic acid, alpha-(3-amino-3-oxopropyl)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxo

C28H38N2O7 (514.2679)

C26H42O10

C26H42O10 (514.2778)

5-amino-2-(3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl)-5-oxopentanoic acid

C28H38N2O7 (514.2679)

5-amino-2-(3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl)-5-oxopentanoic acid_major

C28H38N2O7 (514.2679)

5-amino-2-(3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl)-5-oxopentanoic acid_88.2\\%

C28H38N2O7 (514.2679)

DIHYDROFISSINOLIDE_major

C29H38O8 (514.2567)

DIHYDROFISSINOLIDE_31.9\\%

C29H38O8 (514.2567)

Ala Val Tyr Tyr

C26H34N4O7 (514.2427)

Ala Tyr Val Tyr

C26H34N4O7 (514.2427)

Ala Tyr Tyr Val

C26H34N4O7 (514.2427)

Cys His Lys Lys

C21H38N8O5S (514.2686)

Cys Lys His Lys

C21H38N8O5S (514.2686)

Cys Lys Lys His

C21H38N8O5S (514.2686)

Asp Lys Pro Arg

C21H38N8O7 (514.2863)

Asp Lys Arg Pro

C21H38N8O7 (514.2863)

Asp Pro Lys Arg

C21H38N8O7 (514.2863)

Asp Pro Gln Arg

C20H34N8O8 (514.2499)

Asp Pro Arg Lys

C21H38N8O7 (514.2863)

Asp Pro Arg Gln

C20H34N8O8 (514.2499)

Asp Gln Pro Arg

C20H34N8O8 (514.2499)

Asp Gln Arg Pro

C20H34N8O8 (514.2499)

Asp Arg Lys Pro

C21H38N8O7 (514.2863)

Asp Arg Pro Lys

C21H38N8O7 (514.2863)

Asp Arg Pro Gln

C20H34N8O8 (514.2499)

Asp Arg Gln Pro

C20H34N8O8 (514.2499)

Glu Asn Pro Arg

C20H34N8O8 (514.2499)

Glu Asn Arg Pro

C20H34N8O8 (514.2499)

Glu Pro Asn Arg

C20H34N8O8 (514.2499)

Glu Pro Arg Asn

C20H34N8O8 (514.2499)

Glu Arg Asn Pro

C20H34N8O8 (514.2499)

Glu Arg Pro Asn

C20H34N8O8 (514.2499)

Phe Phe Thr Thr

C26H34N4O7 (514.2427)

Phe Ser Val Tyr

C26H34N4O7 (514.2427)

Phe Ser Tyr Val

C26H34N4O7 (514.2427)

Phe Thr Phe Thr

C26H34N4O7 (514.2427)

Phe Thr Thr Phe

C26H34N4O7 (514.2427)

Phe Val Ser Tyr

C26H34N4O7 (514.2427)

Phe Val Tyr Ser

C26H34N4O7 (514.2427)

Phe Tyr Ser Val

C26H34N4O7 (514.2427)

Phe Tyr Val Ser

C26H34N4O7 (514.2427)

Gly Ile Tyr Tyr

C26H34N4O7 (514.2427)

Gly Leu Tyr Tyr

C26H34N4O7 (514.2427)

Gly Pro Arg Trp

C24H34N8O5 (514.2652)

Gly Pro Trp Arg

C24H34N8O5 (514.2652)

Gly Arg Pro Trp

C24H34N8O5 (514.2652)

Gly Arg Trp Pro

C24H34N8O5 (514.2652)

Gly Trp Pro Arg

C24H34N8O5 (514.2652)

Gly Trp Arg Pro

C24H34N8O5 (514.2652)

Gly Tyr Ile Tyr

C26H34N4O7 (514.2427)

Gly Tyr Leu Tyr

C26H34N4O7 (514.2427)

Gly Tyr Tyr Ile

C26H34N4O7 (514.2427)

Gly Tyr Tyr Leu

C26H34N4O7 (514.2427)

His Cys Lys Lys

C21H38N8O5S (514.2686)

His Lys Cys Lys

C21H38N8O5S (514.2686)

His Lys Lys Cys

C21H38N8O5S (514.2686)

His Pro Val Tyr

C25H34N6O6 (514.254)

His Pro Tyr Val

C25H34N6O6 (514.254)

His Val Pro Tyr

C25H34N6O6 (514.254)

His Val Tyr Pro

C25H34N6O6 (514.254)

His Tyr Pro Val

C25H34N6O6 (514.254)

His Tyr Val Pro

C25H34N6O6 (514.254)

Ile Gly Tyr Tyr

C26H34N4O7 (514.2427)

Ile Tyr Gly Tyr

C26H34N4O7 (514.2427)

Ile Tyr Tyr Gly

C26H34N4O7 (514.2427)

Lys Cys His Lys

C21H38N8O5S (514.2686)

Lys Cys Lys His

C21H38N8O5S (514.2686)

Lys Asp Pro Arg

C21H38N8O7 (514.2863)

Lys Asp Arg Pro

C21H38N8O7 (514.2863)

Lys His Cys Lys

C21H38N8O5S (514.2686)

Lys His Lys Cys

C21H38N8O5S (514.2686)

Lys Lys Cys His

C21H38N8O5S (514.2686)

Lys Lys His Cys

C21H38N8O5S (514.2686)

Lys Pro Asp Arg

C21H38N8O7 (514.2863)

Lys Pro Arg Asp

C21H38N8O7 (514.2863)

Lys Arg Asp Pro

C21H38N8O7 (514.2863)

Lys Arg Pro Asp

C21H38N8O7 (514.2863)

Leu Gly Tyr Tyr

C26H34N4O7 (514.2427)

Leu Tyr Gly Tyr

C26H34N4O7 (514.2427)

Leu Tyr Tyr Gly

C26H34N4O7 (514.2427)

Asn Glu Pro Arg

C20H34N8O8 (514.2499)

Asn Glu Arg Pro

C20H34N8O8 (514.2499)

Asn Pro Glu Arg

C20H34N8O8 (514.2499)

Asn Pro Arg Glu

C20H34N8O8 (514.2499)

Asn Pro Val Trp

C25H34N6O6 (514.254)

Asn Pro Trp Val

C25H34N6O6 (514.254)

Asn Arg Glu Pro

C20H34N8O8 (514.2499)

Asn Arg Pro Glu

C20H34N8O8 (514.2499)

Asn Val Pro Trp

C25H34N6O6 (514.254)

Asn Val Trp Pro

C25H34N6O6 (514.254)

Asn Trp Pro Val

C25H34N6O6 (514.254)

Asn Trp Val Pro

C25H34N6O6 (514.254)

Pro Asp Lys Arg

C21H38N8O7 (514.2863)

Pro Asp Gln Arg

C20H34N8O8 (514.2499)

Pro Asp Arg Lys

C21H38N8O7 (514.2863)

Pro Asp Arg Gln

C20H34N8O8 (514.2499)

Pro Glu Asn Arg

C20H34N8O8 (514.2499)

Pro Glu Arg Asn

C20H34N8O8 (514.2499)

Pro Gly Arg Trp

C24H34N8O5 (514.2652)

Pro Gly Trp Arg

C24H34N8O5 (514.2652)

Pro His Val Tyr

C25H34N6O6 (514.254)

Pro His Tyr Val

C25H34N6O6 (514.254)

Pro Lys Asp Arg

C21H38N8O7 (514.2863)

Pro Lys Arg Asp

C21H38N8O7 (514.2863)

Pro Asn Glu Arg

C20H34N8O8 (514.2499)

Pro Asn Arg Glu

C20H34N8O8 (514.2499)

Pro Asn Val Trp

C25H34N6O6 (514.254)

Pro Asn Trp Val

C25H34N6O6 (514.254)

Pro Gln Asp Arg

C20H34N8O8 (514.2499)

Pro Gln Arg Asp

C20H34N8O8 (514.2499)

Pro Arg Asp Lys

C21H38N8O7 (514.2863)

Pro Arg Asp Gln

C20H34N8O8 (514.2499)

Pro Arg Glu Asn

C20H34N8O8 (514.2499)

Pro Arg Gly Trp

C24H34N8O5 (514.2652)

Pro Arg Lys Asp

C21H38N8O7 (514.2863)

Pro Arg Asn Glu

C20H34N8O8 (514.2499)

Pro Arg Gln Asp

C20H34N8O8 (514.2499)

Pro Arg Trp Gly

C24H34N8O5 (514.2652)

Pro Val His Tyr

C25H34N6O6 (514.254)

Pro Val Asn Trp

C25H34N6O6 (514.254)

Pro Val Trp Asn

C25H34N6O6 (514.254)

Pro Val Tyr His

C25H34N6O6 (514.254)

Pro Trp Gly Arg

C24H34N8O5 (514.2652)

Pro Trp Asn Val

C25H34N6O6 (514.254)

Pro Trp Arg Gly

C24H34N8O5 (514.2652)

Pro Trp Val Asn

C25H34N6O6 (514.254)

Pro Tyr His Val

C25H34N6O6 (514.254)

Pro Tyr Val His

C25H34N6O6 (514.254)

Gln Asp Pro Arg

C20H34N8O8 (514.2499)

Gln Asp Arg Pro

C20H34N8O8 (514.2499)

Gln Pro Asp Arg

C20H34N8O8 (514.2499)

Gln Pro Arg Asp

C20H34N8O8 (514.2499)

Gln Arg Asp Pro

C20H34N8O8 (514.2499)

Gln Arg Pro Asp

C20H34N8O8 (514.2499)

Arg Asp Lys Pro

C21H38N8O7 (514.2863)

Arg Asp Pro Lys

C21H38N8O7 (514.2863)

Arg Asp Pro Gln

C20H34N8O8 (514.2499)

Arg Asp Gln Pro

C20H34N8O8 (514.2499)

Arg Glu Asn Pro

C20H34N8O8 (514.2499)

Arg Glu Pro Asn

C20H34N8O8 (514.2499)

Arg Gly Pro Trp

C24H34N8O5 (514.2652)

Arg Gly Trp Pro

C24H34N8O5 (514.2652)

Arg Lys Asp Pro

C21H38N8O7 (514.2863)

Arg Lys Pro Asp

C21H38N8O7 (514.2863)

Arg Asn Glu Pro

C20H34N8O8 (514.2499)

Arg Asn Pro Glu

C20H34N8O8 (514.2499)

Arg Pro Asp Lys

C21H38N8O7 (514.2863)

Arg Pro Asp Gln

C20H34N8O8 (514.2499)

Arg Pro Glu Asn

C20H34N8O8 (514.2499)

Arg Pro Gly Trp

C24H34N8O5 (514.2652)

Arg Pro Lys Asp

C21H38N8O7 (514.2863)

Arg Pro Asn Glu

C20H34N8O8 (514.2499)

Arg Pro Gln Asp

C20H34N8O8 (514.2499)

Arg Pro Trp Gly

C24H34N8O5 (514.2652)

Arg Gln Asp Pro

C20H34N8O8 (514.2499)

Arg Gln Pro Asp

C20H34N8O8 (514.2499)

Arg Trp Gly Pro

C24H34N8O5 (514.2652)

Arg Trp Pro Gly

C24H34N8O5 (514.2652)

Ser Phe Val Tyr

C26H34N4O7 (514.2427)

Ser Phe Tyr Val

C26H34N4O7 (514.2427)

Ser Val Phe Tyr

C26H34N4O7 (514.2427)

Ser Val Tyr Phe

C26H34N4O7 (514.2427)

Ser Tyr Phe Val

C26H34N4O7 (514.2427)

Ser Tyr Val Phe

C26H34N4O7 (514.2427)

Thr Phe Phe Thr

C26H34N4O7 (514.2427)

Thr Phe Thr Phe

C26H34N4O7 (514.2427)

Thr Thr Phe Phe

C26H34N4O7 (514.2427)

Val Ala Tyr Tyr

C26H34N4O7 (514.2427)

Val Phe Ser Tyr

C26H34N4O7 (514.2427)

Val Phe Tyr Ser

C26H34N4O7 (514.2427)

Val His Pro Tyr

C25H34N6O6 (514.254)

Val His Tyr Pro

C25H34N6O6 (514.254)

Val Asn Pro Trp

C25H34N6O6 (514.254)

Val Asn Trp Pro

C25H34N6O6 (514.254)

Val Pro His Tyr

C25H34N6O6 (514.254)

Val Pro Asn Trp

C25H34N6O6 (514.254)

Val Pro Trp Asn

C25H34N6O6 (514.254)

Val Pro Tyr His

C25H34N6O6 (514.254)

Val Ser Phe Tyr

C26H34N4O7 (514.2427)

Val Ser Tyr Phe

C26H34N4O7 (514.2427)

Val Trp Asn Pro

C25H34N6O6 (514.254)

Val Trp Pro Asn

C25H34N6O6 (514.254)

Val Tyr Ala Tyr

C26H34N4O7 (514.2427)

Val Tyr Phe Ser

C26H34N4O7 (514.2427)

Val Tyr His Pro

C25H34N6O6 (514.254)

Val Tyr Pro His

C25H34N6O6 (514.254)

Val Tyr Ser Phe

C26H34N4O7 (514.2427)

Val Tyr Tyr Ala

C26H34N4O7 (514.2427)

Trp Gly Pro Arg

C24H34N8O5 (514.2652)

Trp Gly Arg Pro

C24H34N8O5 (514.2652)

Trp Asn Pro Val

C25H34N6O6 (514.254)

Trp Asn Val Pro

C25H34N6O6 (514.254)

Trp Pro Gly Arg

C24H34N8O5 (514.2652)

Trp Pro Asn Val

C25H34N6O6 (514.254)

Trp Pro Arg Gly

C24H34N8O5 (514.2652)

Trp Pro Val Asn

C25H34N6O6 (514.254)

Trp Arg Gly Pro

C24H34N8O5 (514.2652)

Trp Arg Pro Gly

C24H34N8O5 (514.2652)

Trp Val Asn Pro

C25H34N6O6 (514.254)

Trp Val Pro Asn

C25H34N6O6 (514.254)

Tyr Ala Val Tyr

C26H34N4O7 (514.2427)

Tyr Ala Tyr Val

C26H34N4O7 (514.2427)

Tyr Phe Ser Val

C26H34N4O7 (514.2427)

Tyr Phe Val Ser

C26H34N4O7 (514.2427)

Tyr Gly Ile Tyr

C26H34N4O7 (514.2427)

Tyr Gly Leu Tyr

C26H34N4O7 (514.2427)

Tyr Gly Tyr Ile

C26H34N4O7 (514.2427)

Tyr Gly Tyr Leu

C26H34N4O7 (514.2427)

Tyr His Pro Val

C25H34N6O6 (514.254)

Tyr His Val Pro

C25H34N6O6 (514.254)

Tyr Ile Gly Tyr

C26H34N4O7 (514.2427)

Tyr Ile Tyr Gly

C26H34N4O7 (514.2427)

Tyr Leu Gly Tyr

C26H34N4O7 (514.2427)

Tyr Leu Tyr Gly

C26H34N4O7 (514.2427)

Tyr Pro His Val

C25H34N6O6 (514.254)

Tyr Pro Val His

C25H34N6O6 (514.254)

Tyr Ser Phe Val

C26H34N4O7 (514.2427)

Tyr Ser Val Phe

C26H34N4O7 (514.2427)

Tyr Val Ala Tyr

C26H34N4O7 (514.2427)

Tyr Val Phe Ser

C26H34N4O7 (514.2427)

Tyr Val His Pro

C25H34N6O6 (514.254)

Tyr Val Pro His

C25H34N6O6 (514.254)

Tyr Val Ser Phe

C26H34N4O7 (514.2427)

Tyr Val Tyr Ala

C26H34N4O7 (514.2427)

Tyr Tyr Ala Val

C26H34N4O7 (514.2427)

Tyr Tyr Gly Ile

C26H34N4O7 (514.2427)

Tyr Tyr Gly Leu

C26H34N4O7 (514.2427)

Tyr Tyr Ile Gly

C26H34N4O7 (514.2427)

Tyr Tyr Leu Gly

C26H34N4O7 (514.2427)

Tyr Tyr Val Ala

C26H34N4O7 (514.2427)

DPNGL

C21H34N6O9 (514.2387)

NGPVE

C21H34N6O9 (514.2387)

DIHYDROFISSINOLIDE

C29H38O8 (514.2567)

3β-ACETOXYDEOXYANGOLENSIC ACID, METHYL ESTER

C29H38O8 (514.2567)

14,15-HxA3-D(11S)

C25H42N2O7S (514.2713)

Capsianside V

C26H42O10 (514.2778)

Cinncassiol D1 glucoside

C26H42O10 (514.2778)

Cinncassiol D4 2-glucoside

C26H42O10 (514.2778)

Cofaryloside

C26H42O10 (514.2778)

Glycinoeclepin C

C29H38O8 (514.2567)

AM-1638

C33H35FO4 (514.2519)

2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,2-methyloxirane,oxirane,propane-1,2,3-triol

C26H39ClO8 (514.2333)

4,4-(1,2-Ethenediyl)bis[N,N-diphenylbenzenamine]

C38H30N2 (514.2409)

N,N-diphenyl-4-[2-[4-(N-phenylanilino)phenyl]ethenyl]aniline

C38H30N2 (514.2409)

4-[(1,7-Dimethyl-2-propyl[2,5-bi-1H-benzimidazol]-1-yl)methyl][1,1-biphenyl]-2-carboxylic Acid

C33H30N4O2 (514.2369)

trans-Ned 19

C30H31FN4O3 (514.238)

3-[2-(4-Aminophenyl)ethyl]-8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

C31H35FN4O2 (514.2744)

17-(1-Hydroxyethyl)-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,12,18,20-tetraene-26,2-oxirane]-11,22-dione

C29H38O8 (514.2567)

Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-

C26H44NO7S- (514.2838)

Taurohyocholate anion

C26H44NO7S- (514.2838)

Tauro-beta-muricholate

C26H44NO7S- (514.2838)

A cholanic acid conjugate anion that is the conjugate base of tauro-beta-muricholic acid arising from deprotonation of the sulfonate OH group; major species at pH 7.3. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

9-[(E)-4-[(2S,4R,5R)-4,5-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]-3-oxooxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

C26H42O10 (514.2778)

PA(2:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C25H39O9P (514.2332)

PA(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0)

C25H39O9P (514.2332)

PA(2:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C25H39O9P (514.2332)

PA(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0)

C25H39O9P (514.2332)

PA(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C25H39O9P (514.2332)

PA(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0)

C25H39O9P (514.2332)

PA(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C25H39O9P (514.2332)

PA(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0)

C25H39O9P (514.2332)

PA(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C25H39O9P (514.2332)

PA(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0)

C25H39O9P (514.2332)

PA(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C25H39O9P (514.2332)

PA(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0)

C25H39O9P (514.2332)

1-[3-[[4-(4-fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid

C30H31FN4O3 (514.238)

Tauroallocholate

C26H44NO7S- (514.2838)

Tauro-alpha-muricholate(1-)

C26H44NO7S- (514.2838)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

1,2-Diheptanoyl-1,2-dithio-sn-glycero-3-phosphocholine

C22H45NO6PS2+ (514.2426)

(3S,3aR,4S,6aS,7E,10S,11E,13R,14S,15Z,17aS)-13,14-dihydroxy-3-(1H-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3,3a,4,6a,9,10,13,14-octahydro-1H-cyclotrideca[d]isoindole-1,17(2H)-dione

C32H38N2O4 (514.2831)

Tauroursocholate

C26H44NO7S- (514.2838)

An organosulfonate oxoanion that is the conjugate base of tauroursocholic acid, obtained by the deprotonation of the sulfonic acid group. It is the major microspecies at pH 7.3.

(2S)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2S)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2S)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

(2S)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2S)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide

C27H38N4O6 (514.2791)

N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide

C30H34N4O4 (514.258)

(2R)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2R)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

N-[(2R,4aR,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide

C27H38N4O6 (514.2791)

N-[(2S,4aR,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide

C27H38N4O6 (514.2791)

N-[(2R,4aR,12aR)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide

C27H38N4O6 (514.2791)

1-(3-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

1-(3-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

(2S)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

N-[(2R,4aS,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide

C27H38N4O6 (514.2791)

N-[(2S,4aR,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide

C27H38N4O6 (514.2791)

(3aR,4R,9bS)-8-[3-[dimethylamino(oxo)methyl]phenyl]-4-(hydroxymethyl)-N-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

C30H34N4O4 (514.258)

(2S)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(4R,7R,8S)-N-(2-fluorophenyl)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C27H35FN4O5 (514.2591)

1-(3-fluorophenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

1-(3-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

1-(3-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

1-(3-fluorophenyl)-3-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

1-(3-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C27H35FN4O5 (514.2591)

(2R)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2R)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

N-[(2S,4aS,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide

C27H38N4O6 (514.2791)

N-[(2S,4aS,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide

C27H38N4O6 (514.2791)

(3aS,4S,9bR)-8-[3-[dimethylamino(oxo)methyl]phenyl]-4-(hydroxymethyl)-N-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

C30H34N4O4 (514.258)

(2R)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2R)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(2R)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide

C32H38N2O4 (514.2831)

(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(3-pyridinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C30H31FN4O3 (514.238)

(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-1-(3-pyridinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C30H31FN4O3 (514.238)

(1R,3R,8R,17S,20Z,24R,25S,26S)-17-[(1S)-1-hydroxyethyl]-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,12,18,20-tetraene-26,2-oxirane]-11,22-dione

C29H38O8 (514.2567)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C26H43O8P (514.2695)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C26H43O8P (514.2695)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C26H43O8P (514.2695)

Capsianoside V

C26H42O10 (514.2778)

Taurocholate

C26H44NO7S (514.2838)

An organosulfonate oxoanion that is the conjugate base of taurocholic acid.

SQMG 13:0

C22H42O11S (514.2448)

MGGA 17:3

C26H42O10 (514.2778)

PA O-23:5;O

C26H43O8P (514.2695)

PA P-16:1/7:3;O

C26H43O8P (514.2695)

LPA 22:6;O2

C25H39O9P (514.2332)

PA 18:4/4:1;O

C25H39O9P (514.2332)

PEth 21:4

C26H43O8P (514.2695)

PM 21:5;O

C25H39O9P (514.2332)

PM 22:4

C26H43O8P (514.2695)

ST 19:1;O5;GlcA

C25H38O11 (514.2414)

ST 20:0;O4;GlcA

C26H42O10 (514.2778)

ST 23:5;O2;GlcA

C29H38O8 (514.2567)

ST 19:2;O6;Hex

C25H38O11 (514.2414)

ST 20:1;O5;Hex

C26H42O10 (514.2778)

ST 23:6;O3;Hex

C29H38O8 (514.2567)

ST 26:2;O5;S

C26H42O8S (514.26)

ST 29:7;O3;S

C29H38O6S (514.2389)

ST 29:7;O8

C29H38O8 (514.2567)

1-[1-(4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl)-1-hydroxyethyl]-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,9h,9bh,10h-cyclopenta[a]phenanthrene-5,8,11-trione

C29H38O8 (514.2567)

(3s,4as,6s,6ar,7r,10ar,10br)-6a-[(acetyloxy)methyl]-7-(chloromethyl)-7-hydroxy-4a,10b-dimethyl-5'-oxo-octahydrospiro[naphtho[2,1-b]pyran-3,3'-oxolan]-6-yl 2-methylpropanoate

C26H39ClO8 (514.2333)

(1'r,2s,3'r,8'r,12'e,17'r,18'e,20'z,24'r,25's)-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5r,9s,10r,13s,14s)-13,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione

C32H38N2O4 (514.2831)

(1s,4s,5r,8s,9s,10r,13r,14r)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C26H42O10 (514.2778)

(3s,3ar,4s,6as,10s,13r,17ar)-1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione

C32H38N2O4 (514.2831)

(1r,3r,4r,6s,8s,10s,13r,14r)-5,5,14-trimethyl-9-methylidene-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,10,14-tetrol

C26H42O10 (514.2778)

6-(acetyloxy)-7-[(acetyloxy)methyl]-5-hydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl 2-methylbut-2-enoate

C29H38O8 (514.2567)

(1r,4s,5s,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-5,9-dimethyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde

C26H42O10 (514.2778)

(1s,3ar,5ar,7r,9ar,9br,11ar)-1-[(1r)-1-[(2r)-4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,9h,9bh,10h-cyclopenta[a]phenanthrene-5,8,11-trione

C29H38O8 (514.2567)

(1''r,2s,2'r,5''as,7''as,11''as,11''bs)-4,5,5'',5'',7''a,9'',11''b-heptamethyl-3,3'',5'-trioxo-2'',5''a,6'',7'',11'',11''a-hexahydro-1''h-dispiro[furan-2,4'-oxolane-2',8''-naphtho[2,1-c]oxepin]-1''-yl acetate

C29H38O8 (514.2567)

(11s,14r,16s,24s)-23-acetyl-10,13-dihydroxy-11-isopropyl-16-(2-methylbut-3-en-2-yl)-1,9,12,23-tetraazapentacyclo[12.10.0.0³,⁸.0¹⁶,²⁴.0¹⁷,²²]tetracosa-3,5,7,9,12,17,19,21-octaen-2-one

C30H34N4O4 (514.258)

(1s,2r,3r,4s,4ar,5r,8as)-3-(acetyloxy)-4-(benzoyloxy)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5,8a-dimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxirane]-5-carboxylic acid

C29H38O8 (514.2567)

9-deacetyl-9-benzoyl-10-debenzoyl brevifoliol

C29H38O8 (514.2567)

{"Ingredient_id": "HBIN014079","Ingredient_name": "9-deacetyl-9-benzoyl-10-debenzoyl brevifoliol","Alias": "9-deacetyl-9-benzoyl-10-debenzoylbrevifoliol","Ingredient_formula": "C29H38O8","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3CC2(CC1O)C(C)(C)O)O)OC(=O)C)C)OC(=O)C4=CC=CC=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26031;4728","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2e,4r,6e,10z,14s)-4-hydroxy-10-(hydroxymethyl)-2,6,14-trimethyl-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,6,10,15-tetraenoic acid

C26H42O10 (514.2778)

(1'r,2s,3's,8's,12'e,17's,18'r,19'e,21'z,25'r,26's)-18'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24'-tetraoxaspiro[oxirane-2,27'-tetracyclo[23.2.1.0³,⁸.0⁸,²⁶]octacosane]-4',12',19',21'-tetraene-11',23'-dione

C29H38O8 (514.2567)

(1s,2e,4e,6s,7r,8s,11r,12e,14e,16r,17r,18r,19s)-8-{[(2s,3r,4r,5r)-3-amino-4,5-dihydroxyoxan-2-yl]oxy}-7,18-dihydroxy-7,19-dimethyl-21-azatetracyclo[14.6.0.0⁶,¹¹.0¹⁷,²¹]docosa-2,4,9,12,14-pentaen-22-one

C28H38N2O7 (514.2679)

[(1s,4as,5s,7ar)-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-7-yl]methyl (2e,6r)-8-hydroxy-2,6-dimethyloct-2-enoate

C25H38O11 (514.2414)

3-[(1r,5s,6r,10s,13s,14s)-5,10,14-trimethyl-6-[(2s)-2-methyloxiran-2-yl]-2,3,8-trioxo-14-(3-oxopentyl)-15-oxatetracyclo[8.6.0.0¹,¹³.0⁴,⁹]hexadec-4(9)-en-5-yl]propanoic acid

C29H38O8 (514.2567)

(1'r,3'r,8'r,12'z,19'z,21'z,25'r,26's)-18'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24'-tetraoxaspiro[oxirane-2,27'-tetracyclo[23.2.1.0³,⁸.0⁸,²⁶]octacosane]-4',12',19',21'-tetraene-11',23'-dione

C29H38O8 (514.2567)

3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2,4,6,13,15-hexaen-8-yl 2-methylbut-2-enoate

C29H38O8 (514.2567)

methyl 15-(acetyloxy)-8-methoxy-4,5,7,10,14,14-hexamethyl-6,18-dioxo-19-oxapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-3,7-diene-9-carboxylate

C29H38O8 (514.2567)

(1s,3ar,5ar,8s,9ar,9br,11ar)-1-[(1r)-1-[(2r)-4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-3a,8-dihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,8h,9h,9bh,10h-cyclopenta[a]phenanthrene-5,7,11-trione

C29H38O8 (514.2567)

(5-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-7-yl)methyl 8-hydroxy-2,6-dimethyloct-2-enoate

C25H38O11 (514.2414)

(3ar,4s,6as,10s,13r,17as)-1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione

C32H38N2O4 (514.2831)

4-butyl 1-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl (2r)-2-hydroxy-2-(2-methylpropyl)butanedioate

C25H38O11 (514.2414)

n-[(2r,3s)-1-[(3s,7s,10s,13z)-10-[(2s)-butan-2-yl]-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-3-methyl-1-oxopentan-2-yl]carboximidic acid

C27H38N4O6 (514.2791)

(1r,2r,4s,5s,9r,10s,12s,13r,14r,16r)-2,12,16-trihydroxy-5,9,14-trimethyl-5-({[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

C26H42O10 (514.2778)

(2s,3'r,8'r,12'e,17'r,18'e,20'z,24'r,25's)-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

n-{1-[8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-3-methyl-1-oxopentan-2-yl}carboximidic acid

C27H38N4O6 (514.2791)

4-[(3r,5s,9r,10s,12r,14r,15s,18r,22s,23r)-10,22-dihydroxy-9-methoxy-14,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosa-1,19-dien-19-yl]-5h-furan-2-one

C29H38O8 (514.2567)

(1r,2s,12r,21ar)-13-{[(2s,3r,4r,5r)-3-amino-4,5-dihydroxyoxan-2-yl]oxy}-1,12-dihydroxy-2,12-dimethyl-1h,2h,3h,13h,21ah-pyrrolo[1,2-a]azacyclononadecan-5-one

C28H38N2O7 (514.2679)

4-hydroxy-10-(hydroxymethyl)-2,6,14-trimethyl-14-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,6,10,15-tetraenoic acid

C26H42O10 (514.2778)

4-butyl 1-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl 2-hydroxy-2-(2-methylpropyl)butanedioate

C25H38O11 (514.2414)

(12'z,18'z,20'z)-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

23-acetyl-10,13-dihydroxy-11-isopropyl-16-(2-methylbut-3-en-2-yl)-1,9,12,23-tetraazapentacyclo[12.10.0.0³,⁸.0¹⁶,²⁴.0¹⁷,²²]tetracosa-3,5,7,9,12,17,19,21-octaen-2-one

C30H34N4O4 (514.258)

(1'r,2s,3'r,8'r,12'z,17's,18'z,20'z,24'r,25's)-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

1-[1-(4-ethyl-5-methyl-6-oxo-2,3-dihydropyran-2-yl)-1-hydroxyethyl]-3a,8-dihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,8h,9h,9bh,10h-cyclopenta[a]phenanthrene-5,7,11-trione

C29H38O8 (514.2567)

6,12-bis(furan-3-ylmethyl)-5,11-dihydroxy-3-isopropyl-1,7-dimethyl-9-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C27H38N4O6 (514.2791)

14-hydroxy-14-(hydroxymethyl)-5,9-dimethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C26H42O10 (514.2778)

(18'e)-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

2-butanoyl-6-[(3-butanoyl-2,4-dihydroxy-6-methoxy-5-methylphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C29H38O8 (514.2567)

miophytocen a

C29H38O8 (514.2567)

methyl 15-(acetyloxy)-6-methoxy-4,5,7,10,14,14-hexamethyl-8,18-dioxo-19-oxapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-3,6-diene-9-carboxylate

C29H38O8 (514.2567)

methyl 2-[14-(acetyloxy)-6-(furan-3-yl)-8-hydroxy-1,5,15,15-tetramethyl-17-oxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate

C29H38O8 (514.2567)

(1'r,2s,12'z,17's,18's,19'z,21'z,25'r,26's)-18'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24'-tetraoxaspiro[oxirane-2,27'-tetracyclo[23.2.1.0³,⁸.0⁸,²⁶]octacosane]-4',12',19',21'-tetraene-11',23'-dione

C29H38O8 (514.2567)

(2s,3'r,8'r,12'e,17's,18'e,20'e,24'r,25's)-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

(1'r,2s,3's,8'r,12'e,17'r,18'r,19'e,21'z,25'r,26's)-18'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24'-tetraoxaspiro[oxirane-2,27'-tetracyclo[23.2.1.0³,⁸.0⁸,²⁶]octacosane]-4',12',19',21'-tetraene-11',23'-dione

C29H38O8 (514.2567)

(2s,3'r,8'r,12'z,18'z,20'z,24'r)-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

(1'r,2s,3'r,8'r,17'r,24'r,25's)-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

miophytocen b

C29H38O8 (514.2567)

4-[2,4-dimethoxy-6-(2-oxoheptyl)benzoyloxy]-2-methoxy-6-pentylbenzoic acid

C29H38O8 (514.2567)

4-{10,22-dihydroxy-9-methoxy-14,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosa-1,19-dien-19-yl}-5h-furan-2-one

C29H38O8 (514.2567)

methyl (1r,5r,9r,10s,12s,15s)-15-(acetyloxy)-6-methoxy-4,5,7,10,14,14-hexamethyl-8,18-dioxo-19-oxapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-3,6-diene-9-carboxylate

C29H38O8 (514.2567)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5s,6r,9s,10r,13r,14s)-6,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

(3s,3ar,4s,6as,10s,17ar)-1-hydroxy-5-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione

C32H38N2O4 (514.2831)

methyl (1r,5r,9r,10s,12s,15s)-15-(acetyloxy)-8-methoxy-4,5,7,10,14,14-hexamethyl-6,18-dioxo-19-oxapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-3,7-diene-9-carboxylate

C29H38O8 (514.2567)

(1'r,2s,3'r,8'r,12'e,17's,18'e,20'e,24'r,25's)-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

roridin e

C29H38O8 (514.2567)

8-(acetyloxy)-2,6,10-trihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl benzoate

C29H38O8 (514.2567)

methyl 2-[(1r,2s,5r,6r,8r,13s,14r,16s)-14-(acetyloxy)-6-(furan-3-yl)-8-hydroxy-1,5,15,15-tetramethyl-17-oxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate

C29H38O8 (514.2567)

1,13,14-trihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,14h-cyclotrideca[d]isoindol-17-one

C32H38N2O4 (514.2831)

1-hydroxy-5-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione

C32H38N2O4 (514.2831)

(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-hydroxy-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-14-yl 1-methyl butanedioate

C29H38O8 (514.2567)

17'-(1-hydroxyethyl)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

2,12,16-trihydroxy-5,9,14-trimethyl-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

C26H42O10 (514.2778)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,4s,5s,6r,9s,10r,13s,14s)-6,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

1,14-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,14h,15h,16h-cyclotrideca[d]isoindole-13,17-dione

C32H38N2O4 (514.2831)

(19'e)-18'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24'-tetraoxaspiro[oxirane-2,27'-tetracyclo[23.2.1.0³,⁸.0⁸,²⁶]octacosane]-4',12',19',21'-tetraene-11',23'-dione

C29H38O8 (514.2567)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5s,6r,9s,10r,13r,14r)-6,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

(2e,6e,10z,14s)-4-hydroxy-10-(hydroxymethyl)-2,6,14-trimethyl-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,6,10,15-tetraenoic acid

C26H42O10 (514.2778)

(3s,3ar,4s,6as,10s,14s,17ar)-1,14-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,14h,15h,16h-cyclotrideca[d]isoindole-13,17-dione

C32H38N2O4 (514.2831)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 6,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5s,6r,9s,10s,13r,14s)-6,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

(2s)-1-[(2s)-1-[(2s)-2-({[(2s,5s,6s)-6-(chloromethyl)-5-methoxypiperidin-2-yl](hydroxy)methylidene}amino)-3-methylbutanoyl]piperidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C24H39ClN4O6 (514.2558)

5-hydroxy-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-14-yl 1-methyl butanedioate

C29H38O8 (514.2567)

(3s,6s,9s,12s)-6,12-bis(furan-3-ylmethyl)-5,11-dihydroxy-3-isopropyl-1,7-dimethyl-9-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C27H38N4O6 (514.2791)

4-[11-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C29H38O8 (514.2567)

5,5,14-trimethyl-9-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,10,14-tetrol

C26H42O10 (514.2778)

(1s,2r,4s,7s,8s,11r,12r,13s,17r,19r)-7-(furan-3-yl)-13-methoxy-1,8,12,16,16-pentamethyl-5,15-dioxo-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadecan-19-yl acetate

C29H38O8 (514.2567)

(1's,2r,3'r,12'e,17'r,18'e,20'z,24'r,25's)-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5s,6r,9s,10s,13r,14r)-6,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H42O10 (514.2778)

18'-hydroxy-5',13',17',26'-tetramethyl-2',10',16',24'-tetraoxaspiro[oxirane-2,27'-tetracyclo[23.2.1.0³,⁸.0⁸,²⁶]octacosane]-4',12',19',21'-tetraene-11',23'-dione

C29H38O8 (514.2567)

(1''s,2r,2's,5''ar,7''ar,11''ar,11''br)-4,5,5'',5'',7''a,9'',11''b-heptamethyl-3,3'',5'-trioxo-2'',5''a,6'',7'',11'',11''a-hexahydro-1''h-dispiro[furan-2,4'-oxolane-2',8''-naphtho[2,1-c]oxepin]-1''-yl acetate

C29H38O8 (514.2567)

6,14,15-trihydroxy-5,9-dimethyl-14-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde

C26H42O10 (514.2778)

7-(furan-3-yl)-13-methoxy-1,8,12,16,16-pentamethyl-5,15-dioxo-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadecan-19-yl acetate

C29H38O8 (514.2567)

(4r)-2-butanoyl-6-[(3-butanoyl-2,4-dihydroxy-6-methoxy-5-methylphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C29H38O8 (514.2567)

4-[(3r,5s,9s,10s,12r,14r,15s,18r,22s,23r)-10,22-dihydroxy-9-methoxy-14,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosa-1,19-dien-19-yl]-5h-furan-2-one

C29H38O8 (514.2567)

(3s,3ar,4s,6as,10s,13r,14s,17ar)-1,13,14-trihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,14h-cyclotrideca[d]isoindol-17-one

C32H38N2O4 (514.2831)

(4s)-4-[(1r,3ar,5ar,9as,11s,11ar)-11-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C29H38O8 (514.2567)

(1s,4s,5r,6r,9s,10r,12r,14r)-6-(acetyloxy)-7-[(acetyloxy)methyl]-5-hydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl (2z)-2-methylbut-2-enoate

C29H38O8 (514.2567)

(1'r,3'r,8'r,12'z,17'r,18'z,20'z,24'r,25's)-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',22'-dione

C29H38O8 (514.2567)

(1r,2r,4s,5s,9r,10s,12s,13r,14r,16r)-2,12,16-trihydroxy-5,9,14-trimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

C26H42O10 (514.2778)

(8r,9r,10r)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2,4,6,13,15-hexaen-8-yl (2z)-2-methylbut-2-enoate

C29H38O8 (514.2567)

4,5,5'',5'',7''a,9'',11''b-heptamethyl-3,3'',5'-trioxo-2'',5''a,6'',7'',11'',11''a-hexahydro-1''h-dispiro[furan-2,4'-oxolane-2',8''-naphtho[2,1-c]oxepin]-1''-yl acetate

C29H38O8 (514.2567)

3-[5,10,14-trimethyl-6-(2-methyloxiran-2-yl)-2,3,8-trioxo-14-(3-oxopentyl)-15-oxatetracyclo[8.6.0.0¹,¹³.0⁴,⁹]hexadec-4(9)-en-5-yl]propanoic acid

C29H38O8 (514.2567)